Evaluating Neurofilament Light Chain as a Biomarker to Measure Therapeutic Effect on ALS Disease Progression

Time: 8:30 am
day: Day Two AM


• Exploring the capabilities of neurofilament light chain, poly(GP), poly(GA) and poly(GA) as biomarkers for ALS diagnosis

• Highlighting discrepancies in neurofilament light changes in recent ALS clinical trials

• Discussing serum vs CSF measurements to measure impact on disease